XML 103 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2014
Accounting Policies [Abstract]  
Revenue Payor Mix

During the years ended December 31, 2014 and 2013, the Company’s revenue payor mix was as follows:

 

 

2014

 

 

2013

 

Medicare and Medicaid

 

24

%

 

 

29

%

Commercial health insurance payors

 

67

%

 

 

59

%

Patient self-pay

 

4

%

 

 

5

%

Management fees from affiliates

 

5

%

 

 

7

%

Other

 

5

%

 

 

4

%

Provision for doubtful accounts

 

(5

%)

 

 

(4

%)

 

Allowance for Doubtful Accounts

The activity in the allowances for doubtful accounts for the years ending December 31, 2014 and 2013 follows:

 

 

2014

 

 

2013

 

Balance at beginning of period

$

4,778,915

 

 

$

1,659,337

 

Reclassification (to) from contractual allowance

 

(832,384

)

 

 

1,458,737

 

Provisions recognized as reduction in revenues

 

5,118,194

 

 

 

3,755,035

 

Write-offs, net of recoveries

 

(7,323,154

)

 

 

(2,094,194

)

Balance at end of period

$

1,741,571

 

 

$

4,778,915

 

 

Estimated Useful Lives of Property and Equipment

The estimated useful lives of the Company’s property and equipment are as follows:

 

Asset Class

 

Useful Life

 

 

Furniture and equipment

 

3 to 7 years

 

 

Equipment under capital leases

 

3 to 7 years

 

 

Leasehold improvements

 

5 to 10 years

 

or remaining lease period, whichever is shorter

 

Securities Not Included in Computation of Diluted Earnings (Loss) Per Share from Continuing or Discontinued Operations

The following securities were not included in the computation of diluted earnings (loss) per share from continuing operations or discontinued operations as their effect would be anti-dilutive:

 

 

 

2014

 

2013

Stock options and warrants

 

1,622,796

 

1,836,106

 

Accompanying Consolidated Financial Statements

The financial information included in the accompanying consolidated financial statements and notes thereto reflect the effects of the corrections described in the preceding paragraph.  The following tables set forth the correction of the individual affected line items in the accompanying consolidated financial statements:

 

 

 

Year Ended December 31, 2013

 

 

 

As Previously

Reported

 

 

 

Correction

 

 

 

Restated

 

Earnings per common share (basic and diluted):

 

 

 

 

 

 

 

 

 

 

 

 

Net loss from continuing operations attributable to Foundation Healthcare common stock

 

 

$

 

(1.20

 

)

 

 

$

(0.24

 

)

 

 

$

 

(1.44

 

)

Loss from discontinued operations

 

 

(0.05

)

 

 

(0.01

)

 

 

(0.06

)

Net loss per share attributable to Foundation Healthcare common stock

 

$

 

(1.25

)

 

 

$

(0.25

 

)

 

 

$

 

(1.50

 

)

Weighted average number of common and diluted shares outstanding

 

 

 

16,293,013

 

 

 

 

(2,657,727

 

)

 

 

 

13,635,286

 

Pro forma basic and diluted net loss per share

 

$

(1.26

)

 

$

(0.25

)

 

$

(1.51

)